CAT 1 · G6PD & Angioedema-like Swelling
CAT 2 · AMPD1, Exercise Intolerance & Sleep
TRIGGERS
SOCIAL / MENTAL / FINANCIAL
LIFESTYLE MODIFICATIONS
Clinical Question: In an adult with G6PD deficiency (Seattle variant) and lifelong recurrent non-histaminergic swelling, does oxidative-stress-driven vascular/membrane dysfunction provide a plausible mechanistic bridge to episodic angioedema-like presentations, independent of classical hereditary angioedema (C1-INH) pathways?
Background
G6PD is the rate-limiting enzyme of the pentose phosphate pathway and the principal cellular source of NADPH, which regenerates reduced glutathione. Deficiency leaves red cells and other tissues vulnerable to oxidative injury, classically presenting as episodic hemolysis after oxidant triggers (sulfa drugs, antimalarials, fava beans/favism). Muscle and vascular tissue also rely on glutathione-linked antioxidant defense, so severe deficiency could plausibly extend beyond hemolysis into broader tissue stress responses.
Appraisal of Evidence
Mechanistic literature on the pentose phosphate pathway supports NADPH as the dominant reductive currency for glutathione- and thioredoxin-linked ROS detoxification systemically, not only in erythrocytes. Separate exercise-physiology literature identifies excess exertion, alcohol, tobacco smoke, air pollutants, and psychological stress as established drivers of oxidative stress generally. Neither literature base directly studies G6PD deficiency as a cause of angioedema-type swelling — this remains a patient-generated hypothesis rather than an established clinical entity, and no controlled studies link G6PD status to non-histaminergic edema.
| Domain | Supports link | Limits |
|---|
| Biochemical plausibility | NADPH/glutathione axis is genuinely systemic | No tissue-edema mechanism specified |
| Trigger overlap | Same oxidant triggers precede both hemolysis and swelling in this patient | Single-patient correlation, not causation |
| Treatment response | Antioxidant-supportive measures (NAC, ribose) reportedly help | Unblinded, self-reported, multiple concurrent interventions |
Bottom line: Biologically plausible as a contributing cofactor, but the swelling pattern more likely reflects a separate or overlapping process (see red-herring signal below) than G6PD deficiency acting alone. Should be framed as a hypothesis for further workup, not an established diagnosis.
Related Provocation prompt: #37 Red Herring / Signal-to-Noise Drill — is oxidative stress the primary driver of the edema, or a bystander finding that co-occurs with the real trigger?
Clinical Question: In a patient with heterozygous AMPD1 deficiency and lifelong severe sleep disruption plus exercise intolerance, is there a coherent purine-metabolism mechanism (adenosine/AMP handling) linking the two symptom clusters, and does the reported response to ribose and L-serine support it?
Background
AMPD1 (myoadenylate deaminase) converts AMP to IMP during muscle work, buffering the adenine nucleotide pool; deficiency classically causes exercise-induced myalgia and fatigue. Adenosine, a purine metabolite in the same pathway, is a well-established sleep-promoting and arousal-suppressing signaling molecule.
Appraisal of Evidence
Human physiology data support glycine/L-serine's inter-convertibility and a documented hypnotic effect of oral L-serine, acting through a GABA-A-linked mechanism distinct from glycine's own receptor route. Ribose supplementation is separately described as replenishing the adenine nucleotide pool consumed during exertion in metabolic myopathies, consistent with reported improvements in exercise tolerance. Direct controlled evidence connecting AMPD1 heterozygosity specifically to sleep architecture is anecdotal (patient support-group pattern reports) rather than peer-reviewed, so causal claims about dementia risk or systemic adenosine excess remain speculative.
| Domain | Supports link | Limits |
|---|
| Muscle/exercise axis | Ribose response consistent with published AMPD-pathway rationale | No biopsy/CK confirmation shown |
| Sleep axis | L-serine's hypnotic mechanism is independently documented | Community-reported AMPD1–sleep link, not a validated association |
| Combined hypothesis | Single purine/one-carbon metabolic axis could plausibly touch both | Two coincident supplement effects can look connected without being mechanistically unified |
Bottom line: Symptomatic benefit from ribose and L-serine is well-documented for their individual, separate mechanisms; treat the unifying "AMPD1 + G6PD interaction" hypothesis as an interesting patient-generated model worth structured testing, not a settled explanation.
Related Promption prompt: #12 Differential Diagnosis Deepdive — bridges the patient's own self-tracked supplement response back to testable physiology rather than accepting the causal story outright.
Identified Triggers
Dietary / Metabolic
Fasting / prolonged gaps between meals
Carbohydrate-rich meals (worsens swelling)
Fava beans
Drug / Chemical
Sulfa-class drugs
Antimalarials
Possible cornstarch-filler effect (cimetidine) — unconfirmed
Physical / Environmental
Vigorous or prolonged exertion
Tobacco smoke / air pollutants
Heat exposure (reported pattern)
Psychological
Psychological/emotional stress (self-reported flare association)
Trigger list compiled from the case narrative and timeline; overlap between oxidative (G6PD) and metabolic (suspected GSD) triggers is itself a point of diagnostic ambiguity — see CAT 1 and module #37.
Social, Mental & Financial Insights
Social
Left school and married at 18, relocated
Decades-long diagnostic odyssey across multiple providers/countries
Mental Health
Suicide attempt at age 15, managed-care admission
Anorexia diagnosed at 15 — later re-examined against fasting-sensitive metabolic pattern
ADHD / autism spectrum diagnosis at 35
Dyslexia diagnosis at 35
Financial / Systemic
Implied cumulative cost of a multi-decade, multi-specialist diagnostic odyssey
20+ self-funded, self-directed supplement trials in the absence of a settled diagnosis
Significant intersection between the psychiatric history (age-15 crisis, later ADHD/autism/dyslexia diagnoses) and the physical picture — worth exploring whether earlier findings were misattributed purely to mental health, delaying metabolic/genetic workup (see module #54).
Lifestyle Modifications
Currently Following
Modified low-carbohydrate, high-fat diet
Self-directed supplement regimen (L-serine, ribose, NAC, iron/folate)
Avoidance of known G6PD-trigger foods/drugs (fava beans, sulfa drugs, antimalarials)
Advisable / Not Yet Adopted
Dietitian-supervised (not self-directed) structured fasting/feeding protocol
Formalized, paced exercise program informed by exercise-test results rather than trial-and-error
Sleep hygiene program alongside/independent of L-serine use
Mental-health follow-up integrated with the physical workup, not run in parallel silos
Medical-alert documentation of G6PD status for any future prescriber
Distinguishing what she is already doing from what remains advisable-but-unstarted highlights where structured clinical support — not further self-experimentation — would add the most value.